Home | health | Can Covishield Vaccine Linked to Rare Blood Clot Condition?

Post By : balindra

Published:7 months ago

Can Covishield Vaccine Linked to Rare Blood Clot Condition?

Can Covishield Vaccine Linked to Rare Blood Clot Condition? AstraZeneca admits Fault

Blood clot risk found in AstraZeneca vaccine, but doctors say benefits outweigh risks.


British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca admits its COVID vaccine, Covishield, that was developed by it and was produced by the Serum Institute of India can cause a rare side effect called TTS. TTS stands for Thrombosis with Thrombocytopenia Syndrome. This is a serious condition with blood clots and low platelet count. TTS can be deadly if not treated quickly. AstraZeneca is facing a lawsuit over these rare side effects. 51 cases have been filed against the company.

People also ask

Covishield, the Indian-produced version of the AstraZeneca COVID-19 vaccine, typically causes mild side effects that go away within a day or two.

A very rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS) has been linked to Covishield. TTS causes blood clots and low platelet count.

If you experience any severe or worsening side effects, especially those that could be signs of TTS (like severe headaches, persistent abdominal pain), seek medical attention immediately.

इस आर्टिकल के बारे में, आप अपने विचारो को शेयर कर सकते है जिससे लोगो की काफी हेल्प होगी।

Total comment 0
No comment..
Previous Post Next Post